Finally, as this study focused exclusively on genes associated with inborn errors of immunity, it cannot exclude the possibility that additional generic modifiers may influence the age-related BC risk in BRCA1 mutation carriers [51]. The gene discussed is BRCA1; the disease is breast cancer.